Tau PET Outcomes With Anti-amyloid Immunotherapies

Clinical trial NCT06723015 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06723015
Sponsor: Mayo Clinic
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Cognitive Impairment, Mild Dementia, Mild Alzheimer Disease

Start date: 2025-11-04
Primary completion: 2028-08-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.